AllianceBernstein
KALA icon

AllianceBernstein’s KALA BIO KALA Stock Holding History

AllianceBernstein’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22
Closed -$77K – 3323
2022
Q1 		$77K Sell
22
-9
-29% -$23.6K ﹤0.01% 3135
2021
Q4 		$93K Sell
31
-3
-9% -$13.9K ﹤0.01% 3201
2021
Q3 		$225K Hold
34
– – ﹤0.01% 3056
2021
Q2 		$455K Buy
34
+17
+100% +$267K ﹤0.01% 2849
2021
Q1 		$286K Sell
17
-7
-29% -$137K ﹤0.01% 2927
2020
Q4 		$404K Hold
24
– – ﹤0.01% 2692
2020
Q3 		$440K Hold
24
– – ﹤0.01% 2588
2020
Q2 		$617K Buy
24
+7
+41% +$198K ﹤0.01% 2473
2020
Q1 		$381K Buy
17
+11
+183% +$176K ﹤0.01% 2490
2019
Q4 		$58K Hold
6
– – ﹤0.01% 3087
2019
Q3 		$60K Hold
6
– – ﹤0.01% 3120
2019
Q2 		$100K Buy
+6
New +$99.4K ﹤0.01% 3082
2017
Q4 		– Sell
-8
Closed -$457K – 3052
2017
Q3 		$457K Buy
+8
New +$439K ﹤0.01% 2604

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

AllianceBernstein's KALA Position: Q2 2022 in Review

AllianceBernstein sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 22 shares — an estimated $77K sold.

AllianceBernstein first reported a position in KALA in Q3 2017 and held it in 13 quarters. The position peaked at $617K in Q2 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • AllianceBernstein reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 22 KALA BIO shares in Q2 2022, an estimated $77K.
  • AllianceBernstein first reported a position in KALA BIO in Q3 2017 and held it in 13 quarters.
  • AllianceBernstein's KALA BIO position peaked at $617K in Q2 2020.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.